Items tagged with Research and development
Mike Frick's plenary talk at TB2016 in Durban (post with simple image)
Mike Frick's plenary talk delivered at TB2016 Durban, South Africa, July 16, 2016.
As U.N. General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs (post with simple image)
New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs.
U.N. High-Level Panel on Access to Medicines releases final report (post with simple image)
United Nations Secretary-General’s High-Level Panel on Access to Medicines calls for new deal to close the health innovation and access gap.
Funding for TB research falls to lowest level in seven years (post with simple image)
Treatment Action Group’s Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose shows that the world spent US$620.6 million on TB research and development in 2015, the lowest level of funding since 2008.
Petition to BRICS countries to triple funding for TB R&D (post with simple image)
>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response.
Advocates encourage prioritization of drug-resistant TB research (post with simple image)
TB advocates encourage the Global Antimicrobial Resistance Innovation Fund to prioritize research and development for drug-resistant TB.
Advocates encourage Danaher to continue investments in Cepheid’s TB products (post with simple image)
TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.
Public health groups welcome Johns Hopkins University and Medicines Patent Pool agreement for development of promising new TB drug (post with simple image)
While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability.
Advocates call on Sequella to provide open access to sutezolid data (post with simple image)
TB advocates appeal to Sequella to act in the interest of public health and provide open access to all existing sutezolid data.
G-FINDER report 2016 (post with simple image)
The report analyses trends and patterns in 2015 for 35 neglected diseases - including TB - across 142 product areas including drugs, vaccines, diagnostics, microbicides and vector control products.
Page 16 of 18 · Total posts: 0←First 15 16 17 Last→